The Regulatory Clinic - July 1996
Understanding Analytical Validation Parameters

Dear Clinic: 

Our validation team recently met to define and apply a number of new terms: Ruggedness, reproducibility, intermediate precision, and repeatability. Although we consulted several references, we could not reach a consensus on the intended meanings of these terms as they apply to analytical validations. Can you explain these terms and their significance? Are there any definitive references available?

Divided and Unvalidated, Akron, Ohio

Dear D&U:

Having gone through a similar exercise last year, we certainly can empathize! However, the good news is that we survived, and eventually, concurred. We'll be happy to provide you with our consensus regarding these terms, but first let us offer some background information to explain how we reached agreement.

Since you indicated that you consulted several references during your research, you probably are aware that several publications were issued in 1995 that addressed the issue of analytical method validation. Each of these publications included new definitions of analytical parameters, including those you mentioned in your letter. The three publications we consulted were:

Each of these documents contains specific descriptions of FDA's expectations in the area of method validation, but offers slightly different interpretations of certain parameters. Specifically, the most problematic discrepancies in interpretation are found in definitions for the three new parameters of precision (repeatability, intermediate precision and reproducibility), and the modified parameter of ruggedness. All four of these parameters provide for a measure of the variability of the method; a determination as to which parameters are appropriate for your method depends on the method's intended use, as well as on the size of your staff and capabilities of your facility.

As a first step, we determined that the definitions of these parameters apply to the method as performed in its entirety, i.e., the procedure, equipment, environment, analysts, materials, calculations--essentially everything that can influence the results of the analysis.

We then determined that repeatability and intermediate precision apply to intra-laboratory (within laboratory) variability, and that reproducibility and ruggedness apply to inter-laboratory (between laboratories) variability. In fact, we further agreed that the two inter-laboratory parameters are the same measurements. However, defining the relationships that would be considered inter-laboratory proved to be less simple. For both the reproducibility and ruggedness definitions, "between laboratories" may apply to R&D vs. QC; QC 1 vs. QC 2; Location A vs. Location B; vendor vs. client, etc.

Once these concepts were addressed, we were able to develop "generic" definitions that would be applicable to our diverse clientele, ranging from tightly-staffed biotech start-up firms and small OTC manufacturers, to corporate pharmaceutical and biologics operations housing R&D, tech transfer, and multiple-laboratory environments. (As is evident from the discussion of inter-laboratory relationships above, the availability - or lack - of a multiple-laboratory environment plays an important role in the interpretation of reproducibility and ruggedness parameters.)

With that background in place, following are our consensual interpretations of the terms in question:

For more information on analytical assay validations, see the Special Report entitled, "Validation of Analytical Assays and Test Methods for the Pharmaceutical Laboratory" in the Articles section of this month's Regulatory Forum).

Return to The Regulatory Forum
Write us at accureg@regulatory.com


(c) 1996 BioSearch Inc. d/b/a/ AccuReg


7501 Northwest 4 Street, Suite 210
Plantation, Florida 33317, USA
Telephone: 954-641-6400  Fax: 954-641-6410
Email: accureg@regulatory.com

Contact webmaster

 

Copyright © 2001 AccuReg, Inc. All rights reserved.
No portion of this site may be reproduced without express written consent of AccuReg, Inc.